EMV Capital PLC
LSE:EMVC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EMV Capital PLC
Depreciation & Amortization
EMV Capital PLC
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMV Capital PLC
LSE:EMVC
|
Depreciation & Amortization
£357k
|
CAGR 3-Years
7%
|
CAGR 5-Years
37%
|
CAGR 10-Years
11%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Depreciation & Amortization
$573m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Depreciation & Amortization
$46.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
23%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Depreciation & Amortization
£5.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-4%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Depreciation & Amortization
£2.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Depreciation & Amortization
£2.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
27%
|
CAGR 10-Years
46%
|
|
EMV Capital PLC
Glance View
NetScientific Plc is a deep tech and life sciences venture capital investment company. The firm identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. The company employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. The company secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The company develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The firm has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.
See Also
What is EMV Capital PLC's Depreciation & Amortization?
Depreciation & Amortization
357k
GBP
Based on the financial report for Jun 30, 2025, EMV Capital PLC's Depreciation & Amortization amounts to 357k GBP.
What is EMV Capital PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
11%
Over the last year, the Depreciation & Amortization growth was -20%. The average annual Depreciation & Amortization growth rates for EMV Capital PLC have been 7% over the past three years , 37% over the past five years , and 11% over the past ten years .
